Could a simple injection before and after surgery keep colorectal cancer at bay?
NCT ID NCT05677113
First seen Feb 27, 2026 · Last updated Jun 19, 2026 · Updated 18 times
Summary
This study tests whether a drug called QBECO, given as a self-injection before and after liver surgery, can lower the chance of colorectal cancer coming back or spreading. About 115 adults with colorectal cancer that has spread to the liver will take part. They will inject the drug for at least 11 days before surgery and 41 days after, then be followed for up to 5 years. The goal is to see if this approach improves cancer control compared to standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hamilton Health Science Centre
Hamilton, Ontario, Canada
-
London Health Science Centre
London, Ontario, Canada
-
Sunnybrook Health Science Centre
Toronto, Ontario, L4H1Z9, Canada
-
The Ottawa Hospital
Ottawa, Ontario, Canada
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.